Paul Capital

Carbon Black (NASDAQ: CBLK) is a leading provider of next-generation endpoint security. Carbon Black serves more than 4,300 customers globally, including 35 of the Fortune 100. As a cybersecurity innovator, Carbon Black has pioneered multiple endpoint security categories, including application control, endpoint detection and response (EDR), and next-generation antivirus (NGAV). Leveraging its big data and analytics cloud platform – the Cb Predictive Security Cloud – Carbon Black solutions enable customers to defend against the most advanced cyber threats, including malware, ransomware, and non-malware attacks. Deployed via the cloud, on premise or as a managed service, customers use Carbon Black solutions to lock down critical systems, hunt threats, and replace legacy antivirus.

Recyclebank helps create a more sustainable future by rewarding people for taking everyday green actions with discounts and deals from local and national businesses.

Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test that analyzes a set of multiple proteins and other blood borne biomarkers implicated in the development of diabetes. Tethys BioScience, Inc. was founded in 2002 and is based in Emeryville, California.

Phase III Development is a Software Engineering company with expertise in a wide variety of development technologies. The mission is to provide customers with innovative custom software solutions of superior quality. They deliver on budget and on time.

SpePharm is a European specialty pharmaceutical company dedicated to acquiring, registering and marketing high medical value medicines throughout Europe, essentially for the hospital market. The SpePharm management team has a wealth of global experience within the pharmaceutical industry. In particular, the team has a well-established and in-depth knowledge of the European regulatory system, the hospital market, and niche and orphan products, with novel approaches and proven successes.

On-X Life Technologies develops, manufactures, and offers artificial heart valve replacement and repair products. The company’s product portfolio includes Aortic Heart Valve with Standard Sewing Ring, Aortic Heart Valve with Conform-X Sewing Ring, Aortic Heart Valve with Anatomic Sewing Ring, Mitral Heart Valve with Standard Sewing Ring, Mitral Heart Valve with Conform-X Sewing Ring, Ascending Aortic Prosthesis, Chord-XTM ePTFE Suture, CO2 diffusion catheters, and more. On-X Life Technologies was incorporated in 1994 and is based in Austin, Texas.

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FDA) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.

Prism Pharmaceuticals, Inc., an acute care pharmaceutical company, engages in developing and commercializing cardiovascular injectable products in the United States. Its products include NEXTERONE, an anti arrhythmic agent in the form of injectable amiodarone; and PM103, an intravenous formulation of clopidogrel bisulfate. The company was founded in 2004 and is based in King of Prussia, Pennsylvania.

Verus Pharmaceuticals is a pediatric-oriented company that identifies, develops, and delivers solutions to address the unmet medical needs of children and those who care for them. It offers treatment of asthma, allergies, and related diseases and conditions. The company also offers Twinject, an epinephrine auto-injector for anaphylaxis. Verus Pharmaceuticals is based in San Diego, California.

Roxy is a female sports fashion brand based in Costa Mesa, California, specializing in apparel and accessories. The company offers a diverse range of products, including clothing, swimwear, handbags, backpacks, and shoes, catering to the varied preferences and budgets of its customers. By focusing on women's sports fashion, Roxy aims to provide stylish and functional options for active lifestyles.

eVentures Group operates and invests in internet communications companies.